Who We Are
mRNA-based therapeutics have demonstrated immense potential to revolutionize disease treatment. However, the broad application of genetic medicines remains limited by the challenges of current delivery technologies. At Nanoportal Biotech, our mission is to leverage natural biological mechanisms to develop the next generation of gene delivery systems. We have successfully invented the world's first coacervate-based nucleic acid delivery platform based on mammalian endogenous protein, offering a novel solution for efficient gene delivery. Our first product, the ProteanFect Transfection Reagent Series, is designed to significantly enhance gene delivery efficiency in primary cells and hard-to-transfect cell lines, empowering scientists globally to conduct genetic research with greater efficiency and convenience. In addition, we are collaborating closely with global pharmaceutical and biotech companies to develop a range of cutting-edge gene therapies for clinical use. We welcome researchers and collaborators worldwide to partner with us in advancing more innovative and high-performing gene delivery systems and methods.
CONTACT
